Oneness Biotech Co., Ltd.

Oneness Biotech Co., Ltd., has been granted the Brazil Good Manufacturing Practice (B-GMP) certification for Bonvadis from Brazil ANVISA.

2025-03-25

Statement
No	1	Date of announcement	2025/03/25	Time of announcement	20:52:20
Addresser	Shu-Ling, Cheng	Addresser’s Position	General Manager	Addresser’s Phone Number	02-26558860
Subject	Oneness Biotech Co., Ltd., has been granted the Brazil Good Manufacturing Practice (B-GMP) certification for Bonvadis from Brazil ANVISA.
To which item it meets	Subparagraph 53			Date of events	2025/03/25
Date of occurrence of the event: 2025/03/25 Company Name: Oneness Biotech Co., Ltd. Relationship with the Company (Please enter the Head office or Subsidiary): Head office Mutual shareholding: Not applicable Current development stage: Oneness received the notification today from the agent that Bonvadis Topical Cream has passed the Brazilian Good Manufacturing Practice (B-GMP) certification according to the Brazilian Official Announcement (DOU) issued by ANVISA. Action taken: None Any other matters that need to be specified: The Brazilian Good Manufacturing Practice (B-GMP) certification is a mandatory regulatory requirement for approving medical device certification in Brazil. With the B-GMP certification, Oneness is eligible to apply for medical device product registration in the Brazilian market.

NEWS